April 4, 2018 / 12:37 PM / 4 months ago

BRIEF-Hemispherx Expands Ampligen Early Access Programme To Canada To Treat ME/CFS Patients

April 4 (Reuters) - Hemispherx Biopharma Inc:

* HEMISPHERX EXPANDS AMPLIGEN EARLY ACCESS PROGRAMME TO CANADA TO TREAT ME/CFS PATIENTS

* ‍AMENDED TO INCLUDE MANAGEMENT OF A SAP IN CANADA FOR PATIENTS SUFFERING FROM MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME​

* ‍FIRST COMMERCIAL SIZE BATCH OF AMPLIGEN, WHICH WILL CONTAIN ABOUT 8,300 VIALS, IS ANTICIPATED TO BE AVAILABLE IN MAY​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below